Cymabay Therapeutics Inc (NASDAQ:CBAY)
| 2.95 Delayed Data As of 4:00pm ET |  -0.04 / -1.34%Today’s Change | 2.76 Today|||52-Week Range 6.56 | -12.72% Year-to-Date |
Latest CBAY News | Press Releases
No recent news for Cymabay Therapeutics Inc.
Today’s Trading
| Previous close | 2.99 |
| Today’s open | 2.95 |
| Day’s range | 2.88 - 2.98 |
| Volume | 22,937 |
| Average volume (3 months) | 503,284 |
| Market cap | $245.5M |
Data as of 4:00pm ET, 01/25/2022
Growth & Valuation
| Earnings growth (last year) | +51.74% |
| Earnings growth (this year) | -53.21% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.40 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DITAMCON Distributing C... | +3.16 | +1.87% |
| --FV Pharma Internatio... | 0.00 | 0.00% |
| ---- | ||
| NEUNNeuroGenesis Inc | 0.00 | 0.00% |
Data as of 4:00pm ET, 01/25/2022
Financials
| Next reporting date | March 24, 2022 |
| EPS forecast (this quarter) | -$0.26 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$51.0M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Newark, California |
Forecasts
